Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8551-8560 Newer>

Pharmaceutical Executive March 1, 2013 Henninger & Feldstein	Safeguarding the Value of Patent Assets As small biotech firms test the water in partnerships with Big Pharma, the best calling card is a well-framed strategy on intellectual property.
Pharmaceutical Executive March 1, 2013	Country Report: China China's pharmaceutical industry is making record gains. Four years ago, China was the world's fifth largest market. Now, it has bypassed France and Germany to become the third largest.
Chemistry World March 21, 2013 Phillip Broadwith	AstraZeneca partners with Moderna for $240 million Moderna has developed a way to use messenger RNA (mRNA), the molecule cells use to turn DNA into proteins, to stimulate the production of specific proteins in cells where disease has diminished or eliminated their ability to do so.
Chemistry World March 21, 2013 Andy Extance	Court convicts ex-Aptuit researcher over drug data Steven Eaton, a former employee at drug discovery and development firm Aptuit's Riccarton site in Scotland, produced flawed data over six years.
Chemistry World March 19, 2013 Simon Hadlington	Global AstraZeneca restructuring will cost 1600 jobs The company's global research blueprint will now be centered on the creation of three 'strategic R&D centers' for small molecules and biologics, to be based in Cambridge in the UK, Gaithersburg in Maryland, US, and Molndal in Sweden, to be completed by 2016.
Fast Company April 2013 Neal Ungerleider	What It Takes To Build A Bionic Man A $1 million bionic robot is the first nonhuman to be built entirely from almost-human parts. You can see him this summer at the Smithsonian Museum, in Washington, D.C.
Chemistry World March 18, 2013 Andrew Turley	Interpol teams up with pharma International police service Interpol is teaming up with 29 drug companies to combat the trade in fake medicines.
Chemistry World March 13, 2013 Ned Stafford	Antibiotic resistance is a 'ticking time bomb' Global research efforts to develop new antibiotics need to be accelerated urgently, the UK government's chief medical officer has warned. She adds that that new drugs are desperately needed to fight the 'catastrophic threat' of growing antimicrobial resistance.
Chemistry World March 12, 2013 Anthony King	Googling for new drug side effects Previously unknown prescription drug side effects have been revealed by the searches people do online.
Chemistry World March 6, 2013 Derek Lowe	New antibiotics: what's the hold up? Money's a factor that could be adjusted by regulatory agencies, governments, and foundations. But no amount of cash will keep resistant bacteria from being the hard targets they are.
<Older 8551-8560 Newer> Return to current articles.